Büchsel, Martin
Geisen, Ulrich
Beckenkamp, Clara
Wengenmayer, Tobias
Zieger, Barbara
Westermann, Dirk
Siegel, Patrick M.
Funding for this research was provided by:
Universitätsklinikum Freiburg
Article History
Received: 26 October 2022
Accepted: 28 December 2022
First Online: 10 January 2023
Declarations
:
: This study was carried out in accordance with the declaration of Helsinki. All patients or their legal guardians provided informed consent. The study protocol for the recruitment of ECMO patients was approved by the Ethics Committee of the University Hospital in Freiburg, Germany.
: No identifiable patient information is provided in the manuscript or figures
: MB and UG received travel support from CSL Behring and Takeda Pharmaceutical. BZ received research funding from Takeda, CSL Behring and Biotest. DW received honorary for talks from Abiomed, Abbott, AstraZeneca, Bayer and Novartis. The other authors declare that they have no competing interests.